Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Heart Journal

• Publication date

  2015-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehv352PMID 26248570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Restoration of renal function does not correct impairment of uremic HDL properties.

  2015cited by this paper
• Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.

  2015cited by this paper
• HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

  2015cited by this paper
• Carbamylated low-density lipoprotein induces endothelial dysfunction.

  2014cited by this paper
• High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target.

  2014cited by this paper
• Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.

  2014cited by this paper
• HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.

  2014cited by this paper
• Uraemic dyslipidaemia revisited: role of high-density lipoprotein.

  2013cited by this paper
• High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.

  2013cited by this paper
• Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.

  2013cited by this paper
• Effects of dalcetrapib in patients with a recent acute coronary syndrome.

  2012cited by this paper
• Novel biological functions of high-density lipoprotein cholesterol.

  2012cited by this paper
• Serum amyloid A in uremic HDL promotes inflammation.

  2012cited by this paper
• Uremia alters HDL composition and function.

  2011influential reference
• Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

  2010cited by this paper
• Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.

  2009cited by this paper
• EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE (ENDING). FOURTH JOINT TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY AND OTHER SOCIETIES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE

  2008cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events

  2008cited by this paper
• Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

  2007cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• KORA - A Research Platform for Population Based Health Research

  2005cited by this paper
• Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

  2005influential reference
• Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE)

  2004cited by this paper
• Increase in Serum Amyloid A Evoked by Dietary Cholesterol Is Associated With Increased Atherosclerosis in Mice

  2004cited by this paper
• High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

  2003cited by this paper
• High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic Men

  2002cited by this paper
• Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

  2001cited by this paper
• Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.

  2000influential reference
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000influential reference
• Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.

  2000influential reference
• Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction.

  2000influential reference
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000influential reference
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

  1977cited by this paper
• CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS

  1976cited by this paper

• Serum-Amyloid-A to High-Density-Lipoprotein-Cholesterol Ratio: superior biomarker for early diagnosis of coronary artery disease with clinically relevant stenoses and development of machine learning diagnostic model

  2026cites this paper
• Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review

  2025influential citation
• Serum amyloid A in HFpEF and cardiometabolic diseases

  2025cites this paper
• Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases

  2025cites this paper
• HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?

  2025cites this paper
• High-density lipoproteins. Part 2. Impact of disease states on functionality

  2025cites this paper
• High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels

  2025cites this paper
• Serum Amyloid A: A Double-Edged Sword in Health and Disease

  2025cites this paper
• Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction

  2025cites this paper
• High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?

  2025cites this paper
• Comparative Efficacy of Drug Interventions on NAFLD Over 24 Weeks: A Traditional and Network Meta-Analysis of Randomized Controlled Trials

  2024influential citation
• Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

  2024influential citation
• Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?

  2024cites this paper
• Serum proteomic changes related to residual impairment in remittent depression are associated with immune and inflammatory processes

  2024cites this paper
• Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties

  2024cites this paper
• Post-Acute Sequelae and Mitochondrial Aberration in SARS-CoV-2 Infection

  2024cites this paper
• HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.

  2024cites this paper
• Post-translational modifications in kidney diseases and associated cardiovascular risk

  2024cites this paper
• ANGPTL3 is a novel HDL component that regulates HDL function

  2024cites this paper
• The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review

  2023cites this paper
• Labordiagnostik von Fettstoffwechselstörungen

  2023cites this paper
• Inflammatory proteins are associated with mortality in a middle‐aged diverse cohort

  2023cites this paper
• Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention)

  2023cites this paper
• Leukocyte–endothelial interaction in CKD

  2023cites this paper
• Investigating the Correlation between Serum Amyloid A and Infarct-Related Artery Patency Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients

  2023cites this paper
• Serum Lipoprotein(a) and High-Density Lipoprotein Cholesterol Associate with Diabetic Nephropathy: Evidence from Machine Learning Perspectives

  2023cites this paper
• HDL anti-inflammatory function is impaired and associated with high SAA1 and low APOA4 levels in aneurysmal subarachnoid hemorrhage

  2023cites this paper
• Comparison of acute phase response in mice after inhalation and intratracheal instillation of molybdenum disulphide and tungsten particles

  2023cites this paper
• HDL – Quo vadis

  2023cites this paper
• Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction.

  2023cites this paper
• Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein

  2023cites this paper
• CSL112 Infusion Rapidly Increases APOA1 Exchange Rate via Specific Serum Amyloid-Poor HDL Subpopulations When Administered to Patients Post–Myocardial Infarction

  2023cites this paper
• Occupational quartz and particle exposure affect systemic levels of inflammatory markers related to inflammasome activation and cardiovascular disease

  2023cites this paper
• Differences in HDL-related mortality risk between individuals with and without hypertension: A prospective cohort study in UK Biobank.

  2023cites this paper
• Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease

  2023cites this paper
• High-density lipoprotein revisited: biological functions and clinical relevance

  2022cites this paper
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies

  2022cites this paper
• Targeting innate immunity-driven inflammation in CKD and cardiovascular disease

  2022cites this paper
• HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism.

  2022cites this paper
• Protective and therapeutic potentials of HDL and ApoA1 in COVID-19 elderly and chronic illness patients

  2022cites this paper
• A SNP in the 5’ flanking region of the SAA1 gene is associated with serum levels of serum amyloid A and cardiovascular risk factors

  2022cites this paper
• Nanomaterials‐assisted metabolic analysis toward in vitro diagnostics

  2022cites this paper
• Associations of Dietary Cholesterol, Serum Cholesterol, and Egg Consumption With Overall and Cause-Specific Mortality: Systematic Review and Updated Meta-Analysis

  2022cites this paper
• Effects of ABCG1 knockout on proteomic composition of HDL in mice on a chow diet and a high‐fat diet

  2022cites this paper
• New prognostic factor for hepatitis B virus‐related decompensated cirrhosis: Ratio of monocytes to HDL‐cholesterol

  2021cites this paper
• Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes

  2021cites this paper
• High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?

  2021cites this paper
• Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients

  2021cites this paper
• Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis

  2021cites this paper
• Unraveling the Complexity of HDL Remodeling: On the Hunt to Restore HDL Quality

  2021cites this paper
• HDL in the 21st Century

  2021cites this paper
• Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations

  2021cites this paper
• The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions

  2021cites this paper
• Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2

  2021cites this paper
• Effect of High-Density Lipoprotein from Healthy Subjects and Chronic Kidney Disease Patients on the CD14 Expression on Polymorphonuclear Leukocytes

  2021cites this paper
• Study of Some Inflammatory Mediators in the Serum of Patients With Atherosclerosis and Acute Myocardial Infarction

  2021cites this paper
• HDL proteome remodeling associates with COVID-19 severity

  2021cites this paper
• Improvements in High-Density Lipoprotein Quantity and Quality Contribute to the Cardiovascular Benefits by Anti-tumor Necrosis Factor Therapies in Rheumatoid Arthritis: A Systemic Review and Meta-Analysis

  2021cites this paper
• High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?

  2021cites this paper
• Reproducible Determination of High-Density Lipoprotein Proteotypes.

  2021cites this paper
• Cross-Sectional Associations Between HDL Structure or Function, Cell Membrane Fatty Acid Composition, and Inflammation in Elderly Adults.

  2021cites this paper
• Guanidinylated Apolipoprotein C3 (ApoC3) Associates with Kidney and Vascular Injury

  2021cites this paper
• Lipoproteins in chronic kidney disease: from bench to bedside.

  2021cites this paper
• Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting.

  2020cites this paper
• High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.

  2020cites this paper
• On the Chameleonic Behaviour of Cholesterol through a Fractal/Multifractal Model

  2020cites this paper
• Lipide und PCSK9-Inhibition bei chronischer Nierenerkrankung

  2020cites this paper
• Lipid efflux mechanisms, relation to disease and potential therapeutic aspects.

  2020cites this paper
• Quality over Quantity: A Case Based Review of HDL Function and Dysfunction

  2020cites this paper
• Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection

  2020cites this paper
• Sensitive and reproducible determination of clinical HDL proteotypes

  2020cites this paper
• Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients

  2020cites this paper
• Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome.

  2020cites this paper
• Can Active Aerobic Exercise Reduce the Risk of Cardiovascular Disease in Prehypertensive Elderly Women by Improving HDL Cholesterol and Inflammatory Markers?

  2020cites this paper
• Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to SARS-CoV-2 severity

  2020cites this paper
• Structural Basis for Vital Function and Malfunction of Serum Amyloid A: an Acute-Phase Protein that Wears Hydrophobicity on Its Sleeve

  2020cites this paper
• Investigating the pernicious effects of heparan sulfate in serum amyloid A1 protein aggregation: a structural bioinformatics approach

  2020cites this paper
• Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!

  2020cites this paper
• HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study

  2020cites this paper
• Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study

  2020influential citation
• High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?

  2020cites this paper
• Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion

  2020cites this paper
• Inflammatory metabolic profile of South African patients with prostate cancer

  2020cites this paper
• Roles of Serum Amyloid A 1 Protein Isoforms in Rheumatoid Arthritis

  2020cites this paper
• Serum amyloid A 1 protein isoforms induce Rheumatoid Arthritis

  2020cites this paper
• Blood Inflammatory Biomarkers of Cardiovascular Disease

  2019cites this paper
• High-Density Lipoprotein from Chronic Kidney Disease Patients Modulates Polymorphonuclear Leukocytes

  2019cites this paper
• Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation

  2019cites this paper
• Association Between Serum High‐Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW‐CKD

  2019cites this paper
• Altered proteome of high-density lipoproteins from paediatric acute lymphoblastic leukemia survivors

  2019cites this paper
• Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Structure-function relationships of HDL in diabetes and coronary heart disease.

  2019cites this paper
• High-Density Lipoprotein Function and Dysfunction in Health and Disease

  2019influential citation
• Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation

  2019cites this paper
• Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells

  2019cites this paper
• Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation

  2019cites this paper
• Humoral immunity against HDL particle: a new perspective in cardiovascular diseases?

  2019cites this paper
• Cardioprotective Properties Of Hdl: Structural And Functional Considerations.

  2019cites this paper
• SAA1 gene polymorphisms in osteoporosis patients

  2019cites this paper